Multivariable GLM Poisson sub-group analysis on recent CD-4 T-cells count by WHO stage among HIV patients on ART from April, 2015 to January, 2019 in Tigray region, Northern Ethiopia (n = 19525).
Background The newly approved biologics and Janus kinase inhibitors (JAKi) for pediatric atopic dermatitis (AD) offer additional options for clinical treatment. However, the efficacy and safety differ
